AstraZeneca AB,   Sweden

Glucocorticosteroid for topical application
Aerosol for inhalation dosage 40 μg / spray, 80 μg / spray, 160 μg / spray.
Angiotensin II receptor antagonist

Tablets of 8 and 16 mg.

Angiotensin II receptor antagonist

Tablets of 32 mg.

Hypotensive combined agent (angiotensin II receptor blocker + diuretic)
Pills 16 mg + 12.5 mg.
Beta1-blocker selective
Tabletki, 100 mg.
Beta1-blocker selective

Solution for intravenous administration, 1 mg / ml.

Beta1-blocker selective
Tablets with delayed release, coated with a coating, 25 mg, 50 mg and 100 mg.
Antiaggregant agent

Film-coated tablets, 90 mg.

Antiaggregant agent

The tablets covered with a film membrane, 60 mg.

Anti-inflammatory agent - phosphodiesterase 4 (PDE4) inhibitor
Film coated tablets 0.5 mg.
A combined hypotensive drug (beta-blocker + BCCC)
Tablets of prolonged action, film-coated, 50 mg + 5 mg.
glands of the stomach secretion-lowering agent - proton pump inhibitor
local anesthetic
Solution for injection 5 mg / ml.
local anesthetic
Solution for injection 5 mg / ml.
glands of the stomach secretion-lowering agent - proton pump inhibitor
Tablets coated with a coating, 20 mg and 40 mg.
glands of the stomach secretion-lowering agent - proton pump inhibitor

Lyophilizate for the preparation of a solution for intravenous administration of 40 mg.

a means of reducing the secretion of the glands of the stomach - the proton pump inhibitor
Pellets, coated with an enteric coating, and granules for the preparation of a suspension for oral administration, 10 mg
a means of reducing the secretion of the glands of the stomach - the proton pump inhibitor

Pellets, coated with enteric coating, and granules for the preparation of a suspension for oral administration, 10 mg.


Bronchodilator-beta2-adrenergic selective

The powder for inhalation is dosed at 4.5 μg / dose and 9 μg / dose.

Glucocorticosteroid for topical application.
Suspension for inhalations dosed with 0.25 mg / ml and 0.5 mg / ml.
glucocorticosteroid for topical application
Powder for inhalation dosed with 100 μg / dose, 200 μg / dose.
bronchodilating agent combined (beta2-adrenomimetic selective + glucocorticosteroid local)
Powder for inhalation dosed 80 / 4.5 μg / dose and 160 / 4.5 μg / dose.
Bronchodilator combined (beta2-adrenomimetic selective + glucocorticosteroid local)
Powder for inhalation dosed 320 + 9 microgram / dose.
Antitumor agent, protein kinase inhibitor
Pills, film-coated, 40 mg, 80 mg.
Antitumor agent, antiestrogen.
Solution for intramuscular injection 250 mg / 5 ml. 5 ml into a glass syringe with a safe injection system.
Local anesthetic
Cream for local and external use (aluminum tubes) for 5 g and 30 g.
Local anesthetic
Therapeutic system.